Although PIM1 has been established to have a role in cancer progression, there is increasing evidence for wider pathological roles of PIM1 within the context of immunoinflammatory diseases, including Lupus nephritis (LN) and rheumatoid arthritis (RA) (5–7). This evidence concerns the gene PIM1 and rheumatoid arthritis.